Business Standard

Monday, December 23, 2024 | 09:05 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Delhi HC allows Alembic, Natco Pharma to export Bayer drug ingredient

Alembic refused to comments on the issue as they said they had not seen a copy of the judgment, while Bayer and Natco Pharma remained unavailable for comments

Representative image Photo: Shutterstock
Premium

Representative image Photo: Shutterstock

BS Reporter
The Delhi High Court on Monday allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in Bayer’s cancer drug Nexavar, and rivaroxaban, the active ingredient in its blood thinner medicine Xarelto for research and development (R&D) purpose.

A divison Bench of Justice S Ravindra Bhat and Justice Sanjeev Sachdeva, agreeing with majority of the findings of a single judge bench allowing the exports, said the question of whether those samples were being sent only for research and development or not will have to be heard afresh by the court.

Alembic refused to comments on the issue as they said

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in